BIOMARINPHARMA

Company

BIOMARIN PHARMACEUTICAL INC

Filed

March 6, 2009

Accession Number

0001123274-09-000013

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →